Ignite Creation Date:
2024-05-06 @ 2:50 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04446416
Status:
COMPLETED
Last Update Posted:
2023-09-06
First Post:
2020-06-16
Brief Title:
Efficacy and Safety of NaviFUS System add-on Bevacizumab BEV in Recurrent GBM Patients
Sponsor:
NaviFUS Corporation
Organization:
NaviFUS Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-16
First Submit QC Date:
June 23 2020
Study First Post Date:
2020-06-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-04
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL